Intrinsic Value

Lyra Therapeutics, Inc. (LYRA)

$4.03

-0.60 (-12.96%)

Enterprise Value -
Net Debt 4.53
Equity Value -
Shares Outstanding 49.80
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt